NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Institutional Trading Activity


NEUROONE MEDICAL TECHNOLOGIE (NMTC) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCBuy70,428763,028$578,375
Q3 2025Renaissance Technologies LLCBuy223,700692,600$615,444
Q2 2025Renaissance Technologies LLCBuy468,900468,900$318,055

Frequently asked questions about NMTC activity

  • Which institutional owners are buying NMTC?

    Institutional owners buying NMTC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in NMTC activity?

    "Buy" means an investor increased their reported position in NMTC compared to the prior reporting period. This reflects growing exposure to NEUROONE MEDICAL TECHNOLOGIE (NMTC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in NMTC increasing?

    Institutional interest in NMTC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.